Bioleaders Corporation (142760) — Capital Reinvestment Ratio
Bioleaders Corporation (142760) has a Capital Reinvestment Ratio of 21.04x as of September 2024, meaning it reinvests 21% of its operating cash flow (₩49.56 Million) in capital expenditures (₩1.04 Billion). See 142760 net asset quality score to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Bioleaders Corporation Capital Reinvestment Ratio (2023–2023)
This chart tracks Bioleaders Corporation's Capital Reinvestment Ratio across 1 annual periods. Check Bioleaders Corporation (142760) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Bioleaders Corporation (2023–2023)
Year-by-year Capital Reinvestment Ratio for Bioleaders Corporation from 2023 to 2023. For live market cap and broader valuation context, see Bioleaders Corporation (142760) total market value.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.06x | ₩6.18 Billion | ₩378.81 Million | — |